AC Immune Earnings Estimate

ACIU Stock  USD 2.29  0.01  0.43%   
The next projected EPS of AC Immune is estimated to be -0.01925 with future projections ranging from a low of -0.1875 to a high of 0.08975. AC Immune's most recent 12-month trailing earnings per share (EPS TTM) is at -0.58. Please be aware that the consensus of earnings estimates for AC Immune is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
AC Immune is projected to generate -0.01925 in earnings per share on the 31st of December 2025. AC Immune earnings estimates show analyst consensus about projected AC Immune EPS (Earning Per Share). It derives the highest and the lowest estimates based on AC Immune's historical volatility. Many public companies, such as AC Immune, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing AC Immune's earnings estimates, investors can diagnose different trends across AC Immune's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 28.7 M in 2025, whereas Pretax Profit Margin is likely to drop (1.96) in 2025.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

AC Immune Earnings Estimation Breakdown

The calculation of AC Immune's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of AC Immune is estimated to be -0.01925 with the future projection ranging from a low of -0.1875 to a high of 0.08975. Please be aware that this consensus of annual earnings estimates for AC Immune is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.16
-0.19
Lowest
Expected EPS
-0.01925
0.09
Highest

AC Immune Earnings Projection Consensus

Suppose the current estimates of AC Immune's value are higher than the current market price of the AC Immune stock. In this case, investors may conclude that AC Immune is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and AC Immune's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
458.03%
-0.16
-0.01925
-0.58

AC Immune Earnings per Share Projection vs Actual

Actual Earning per Share of AC Immune refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering AC Immune predict the company's earnings will be in the future. The higher the earnings per share of AC Immune, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

AC Immune Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as AC Immune, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of AC Immune should always be considered in relation to other companies to make a more educated investment decision.

ACIU Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact AC Immune's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-03-12
2024-12-31-0.1903-0.160.030315 
2024-11-01
2024-09-30-0.230.060.29126 
2024-08-06
2024-06-300.27-0.23-0.5185 
2024-05-13
2024-03-31-0.14-0.18-0.0428 
2024-03-14
2023-12-31-0.11-0.050.0654 
2023-11-03
2023-09-300.03-0.18-0.21700 
2023-08-04
2023-06-30-0.19-0.2-0.01
2023-04-28
2023-03-31-0.23-0.210.02
2023-03-16
2022-12-31-0.25-0.230.02
2022-10-28
2022-09-30-0.25-0.160.0936 
2022-07-28
2022-06-30-0.24-0.230.01
2022-04-28
2022-03-31-0.22-0.23-0.01
2022-03-22
2021-12-310.1-0.28-0.38380 
2021-11-08
2021-09-30-0.27-0.220.0518 
2021-08-04
2021-06-30-0.24-0.26-0.02
2021-04-28
2021-03-31-0.23-0.230.0
2021-03-23
2020-12-31-0.25-0.27-0.02
2020-11-13
2020-09-30-0.25-0.240.01
2020-08-05
2020-06-30-0.24-0.220.02
2020-05-04
2020-03-31-0.14-0.110.0321 
2020-03-30
2019-12-31-0.22-0.28-0.0627 
2019-11-13
2019-09-300.170.250.0847 
2019-08-14
2019-06-30-0.22-0.24-0.02
2019-05-15
2019-03-311.210.96-0.2520 
2019-03-21
2018-12-310.35-0.2-0.55157 
2018-11-13
2018-09-30-0.25-0.210.0416 
2018-08-08
2018-06-30-0.22-0.190.0313 
2018-05-02
2018-03-31-0.21-0.20.01
2018-03-20
2017-12-310.010.080.07700 
2017-11-13
2017-09-30-0.13-0.15-0.0215 
2017-08-09
2017-06-30-0.16-0.140.0212 
2017-05-11
2017-03-31-0.16-0.17-0.01
2017-03-17
2016-12-31-0.1535-0.09020.063341 
2016-11-11
2016-09-30-0.16-0.18-0.0212 

About AC Immune Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of AC Immune earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current AC Immune estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as AC Immune fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-368.2 M-349.8 M
Earnings Yield(0.15)(0.18)
Price Earnings Ratio(7.55)(7.93)
Price Earnings To Growth Ratio 0.24  0.25 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.